Log In
BCIQ
Print this Print this
 

Epicel

  Manage Alerts
Collapse Summary General Information
Company Vericel Corp.
DescriptionEpidermal autograft consisting of human cells cultured with mouse fibroblasts and bovine serum
Molecular Target Not available
Mechanism of ActionCell therapy
Therapeutic ModalityCell therapy
Latest Stage of DevelopmentMarketed
Standard IndicationBurns
Indication DetailsTreat burns and permanently replace lost skin
Regulatory Designation
Partner

 Product Details
 Archive Items are loading loading
Collapse Summary Deals Information
Total Number of DealsTotal Deal ValueTotal Upfront CashTotal Milestone Payments

1

$6.5M

$4.0M

0


 Deals Details
DateCompanies InvolvedDeal HeadlineTotal Deal ValueTotal Upfront CashTotal Milestone

04/21/2014

$6.5M

$4.0M

0

Get a free BioCentury trial today